Generics - Respiratory and Pulmonary, Patents, Generics

Actavis launches generic Pulmicort Respules in USA


Ireland-based generic drugs major Actavis has launched its generic version of Anglo-Swedish pharma major…

ActavisAstraZenecaGenericsLegalMarkets & MarketingPatentsPulmicort RespulesRespiratory and PulmonaryUSA

Teva gets positive UK judgment in case against AstraZeneca

Teva gets positive UK judgment in case against AstraZeneca


A positive judgment has been given by the UK High Court in support of Israeli generic drug giant Teva…

AstraZenecaDuoResp SpiromaxGenericsLegalPatentsRespiratory and PulmonarySymbicortTeva Pharmaceutical IndustriesUK

United Thera scores over Sandoz in Remodulin patent case

United Thera scores over Sandoz in Remodulin patent case


US biotech company United Therapeutics’ shares leapt 28.5% to $117.83 on Friday, after the company…

GenericsLegalNovartisPatentsRemodulinRespiratory and PulmonarySandozUnited TherapeuticsUSA

US District Court upholds Mylan's US patents on Perforomist Inhalation Solution


US generics major Mylan says the US District Court for the Northern District of West Virginia issued…

GenericsLegalMylan LaboratoriesNorth AmericaPatentsPerforomistRespiratory and PulmonaryTeva Pharmaceutical IndustriesUSA

US District Court issues final judgment in favor of Mylan in Brovana patent dispute


US generics and specialty drugmaker Mylan (Nasdaq: MYL) revealed yesterday (July 8) that the US District…

BrovanaDainippon Sumitomo PharmaGenericsLegalMylan LaboratoriesNorth AmericaPatentsPerforomistPharmaceuticalRespiratory and PulmonarySunovion

Actavis wins generic Pulmicort Respules case; challenges AbbVie patent


US generic drugs maker Actavis (NYSE: ACT) has confirmed that the US District Court for the District…

AbbVieActavisAndroGelAstraZenecaGenericsMarkets & MarketingMen's HealthNorth AmericaPatentsPulmicort RespulesRegulationRespiratory and Pulmonary

Briefs: BDR Pharma seeks Sprycel compulsory license; Hospira gains Precedex extension; Perrigo to start shipping generic Mucinex


Indian generic drugmaker BDR Pharmaceuticals has applied to India's patent office for a compulsory licence…

Asia-PacificBDR PharmaceuticalsBristol-Myers SquibbGenericsHospiraMucinexNeurologicalNorth AmericaOncologyPatentsPerrigoPrecedexRegulationRespiratory and PulmonarySprycel

News briefs: Italy lifts hold on Novartis vaccines; files for QVA149 in Japan; Mylan patent settlement


The Italian Medicines Agency (AIFA) said last Friday that the temporary halt on the use of Swiss drug…

AgrippalAsia-PacificEuropeFluadGenericsJanssenJohnson & JohnsonMylan LaboratoriesNorth AmericaNovartisOrtho Tri-Cyclen LoPatentsPharmaceuticalQVA149RegulationReproductiveRespiratory and PulmonaryVaccines

Mylan in patent settlement with Shionogi over Orapred ODT


US generic drugs major Mylan (Nasdaq: MYL) has entered into a patent settlement with Japan's Shionogi…

CIMA LabsGenericsLegalMylan LaboratoriesNorth AmericaOrapred ODTPatentsRespiratory and PulmonaryShionogi

US patent settlements of Xopenex and Lidoderm


US generics drug major Mylan (Nasdaq: MYL) has entered into a settlement agreement with Sunovion Pharmaceuticals,…

Dainippon Sumitomo PharmaEndo PharmaceuticalsGenericsLidodermMylan LaboratoriesNeurologicalNorth AmericaPatentsRespiratory and PulmonarySunovionWatson PharmaceuticalsXopenex

Mylan settles over Brovana; launches generic Boniva in UK and Italy


US generic drugs major Mylan (Nasdaq: MYL) has entered into an agreement with Sunovion Pharmaceuticals,…

Anti-Arthritics/RheumaticsBonivaBrovanaDainippon Sumitomo PharmaEuropeGenericsMarkets & MarketingMylan LaboratoriesNorth AmericaPatentsRespiratory and PulmonaryRocheSunovion

Back to top